{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T19:14:41Z","timestamp":1792523681004,"version":"4.5.0"},"reference-count":53,"publisher":"The Endocrine Society","issue":"4","license":[{"start":{"date-parts":[[2023,1,31]],"date-time":"2023-01-31T00:00:00Z","timestamp":1675123200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"crossref","award":["21H03103"],"award-info":[{"award-number":["21H03103"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"crossref","award":["19K10040"],"award-info":[{"award-number":["19K10040"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"crossref","award":["22K09911"],"award-info":[{"award-number":["22K09911"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Kyowa Kirin Co., Ltd."}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,2,11]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>To elucidate the effect of evocalcet, a new oral calcimimetic to bone of secondary hyperparathyroidism (SHPT) with chronic kidney disease (CKD), the rats were 5\/6 nephrectomized and fed on a high-phosphate diet. The treated rats were then divided into vehicle groups and evocalcet administered groups. The rats in the vehicle groups exhibited increased levels of serum PTH and inorganic phosphate (Pi) levels, high bone turnover, and severe cortical porosity, mimicking SHPT (CKD-SHPT rats). The cortical bone of the CKD-SHPT rats showed broad demineralization around the osteocytes, suppression of Phex\/small integrin-binding ligand N-linked glycoprotein-mediated mineralization in the periphery of the osteocytic lacunae, and increased levels of osteocytic cell death, all of which were considered as the first steps of cortical porosity. In contrast, evocalcet ameliorated the increased serum PTH levels, the enlarged osteocytic lacunae, and the cortical porosity of the CKD-SHPT rats. Osteocytes of CKD-SHPT rats strongly expressed PTH receptor and Pit1\/Pit2, which sense extracellular Pi, indicating that PTH and Pi affected these osteocytes. Cell death of cultured osteocytes increased in a Pi concentration-dependent manner, and PTH administration rapidly elevated Pit1 expression and enhanced osteocytic death, indicating the possibility that the highly concentrated serum PTH and Pi cause severe perilacunar osteolysis and osteocytic cell death. It is likely therefore that evocalcet not only decreases serum PTH but also reduces the exacerbation combined with PTH and Pi to the demineralization of osteocytic lacunae and osteocytic cell death, thereby protecting cortical porosity in CKD-SHPT rats.<\/jats:p>","DOI":"10.1210\/endocr\/bqad022","type":"journal-article","created":{"date-parts":[[2023,1,31]],"date-time":"2023-01-31T05:57:06Z","timestamp":1675144626000},"source":"Crossref","is-referenced-by-count":29,"title":["Evocalcet Rescues Secondary Hyperparathyroidism-driven Cortical Porosity in CKD Male Rats"],"prefix":"10.1210","volume":"164","author":[{"given":"Tomoka","family":"Hasegawa","sequence":"first","affiliation":[{"name":"Developmental Biology of Hard Tissue, Graduate School of Dental Medicine, and Faculty of Dental Medicine, Hokkaido University, Sapporo , Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shin","family":"Tokunaga","sequence":"additional","affiliation":[{"name":"Medical Affairs Department, Kyowa Kirin Co., Ltd., Tokyo , Japan"},{"name":"Biomedical Science Research Laboratories 1, Research Unit, R&D Division, Kyowa Kirin Co., Ltd., Shizuoka , Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomomaya","family":"Yamamoto","sequence":"additional","affiliation":[{"name":"Developmental Biology of Hard Tissue, Graduate School of Dental Medicine, and Faculty of Dental Medicine, Hokkaido University, Sapporo , Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariko","family":"Sakai","sequence":"additional","affiliation":[{"name":"Biomedical Science Research Laboratories 1, Research Unit, R&D Division, Kyowa Kirin Co., Ltd., Shizuoka , Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiromi","family":"Hongo","sequence":"additional","affiliation":[{"name":"Developmental Biology of Hard Tissue, Graduate School of Dental Medicine, and Faculty of Dental Medicine, Hokkaido University, Sapporo , Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takehisa","family":"Kawata","sequence":"additional","affiliation":[{"name":"Medical Affairs Department, Kyowa Kirin Co., Ltd., Tokyo , Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5844-9343","authenticated-orcid":false,"given":"Norio","family":"Amizuka","sequence":"additional","affiliation":[{"name":"Developmental Biology of Hard Tissue, Graduate School of Dental Medicine, and Faculty of Dental Medicine, Hokkaido University, Sapporo , Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","published-online":{"date-parts":[[2023,1,31]]},"reference":[{"issue":"5","key":"2023022002591409000_","first-page":"397","article-title":"Outcomes of secondary hyperparathyroidism in chronic kidney disease and the direct costs of treatment","volume":"13","author":"Joy","year":"2007","journal-title":"J Manag Care Pharm"},{"issue":"5","key":"2023022002591409000_","doi-asserted-by":"crossref","first-page":"574","DOI":"10.3122\/jabfm.2009.05.090026","article-title":"Secondary hyperparathyroidism: pathophysiology and treatment","volume":"22","author":"Saliba","year":"2009","journal-title":"J Am Board Fam Med"},{"issue":"4","key":"2023022002591409000_","doi-asserted-by":"crossref","first-page":"913","DOI":"10.2215\/CJN.06040710","article-title":"Secondary hyperparathyroidism: pathogenesis, disease progression, and therapeutic options","volume":"6","author":"Cunningham","year":"2011","journal-title":"Clin J Am Soc Nephrol"},{"issue":"13","key":"2023022002591409000_","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1056\/NEJMoa041031","article-title":"Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization","volume":"351","author":"Go","year":"2004","journal-title":"N Engl J Med"},{"key":"2023022002591409000_","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.atherosclerosis.2018.08.046","article-title":"CKD, arterial calcification, atherosclerosis and bone health: inter-relationships and controversies","volume":"278","author":"Reiss","year":"2018","journal-title":"Atherosclerosis"},{"issue":"6","key":"2023022002591409000_","doi-asserted-by":"crossref","first-page":"962","DOI":"10.2215\/CJN.11031017","article-title":"Management of osteoporosis in CKD","volume":"13","author":"Khairallah","year":"2018","journal-title":"Clin J Am Soc Nephrol"},{"issue":"5","key":"2023022002591409000_","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1016\/j.kint.2019.01.045","article-title":"Direct bone effects of calcimimetics in chronic kidney disease?","volume":"95","author":"Mazzaferro","year":"2019","journal-title":"Kidney Int"},{"issue":"5","key":"2023022002591409000_","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.3390\/nu13051670","article-title":"The importance of phosphate control in chronic kidney disease","volume":"13","author":"Tsuchiya","year":"2021","journal-title":"Nutrients"},{"issue":"6","key":"2023022002591409000_","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1002\/jbmr.3094","article-title":"Serum phosphate is associated with fracture risk: the Rotterdam study and MrOS","volume":"32","author":"Campos-Obando","year":"2017","journal-title":"J Bone Miner Res"},{"issue":"3","key":"2023022002591409000_","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1093\/ndt\/gfz196","article-title":"Phosphate and bone fracture risk in chronic kidney disease patients","volume":"36","author":"Fusaro","year":"2021","journal-title":"Nephrol Dial Transplant"},{"issue":"4","key":"2023022002591409000_","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1111\/1744-9987.12772","article-title":"Secondary hyperparathyroidism: pathogenesis and latest treatment","volume":"23","author":"Mizobuchi","year":"2019","journal-title":"Ther Apher Dial"},{"issue":"4","key":"2023022002591409000_","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1007\/s00223-020-00788-y","article-title":"Old and new drugs for the management of bone disorders in CKD","volume":"108","author":"Komaba","year":"2021","journal-title":"Calcif Tissue Int"},{"issue":"9","key":"2023022002591409000_","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1359\/jbmr.090413","article-title":"Intermittent PTH administration stimulates pre-osteoblastic proliferation without leading to enhanced bone formation in osteoclast-less c-fos(-\/-) mice","volume":"24","author":"de Freitas","year":"2009","journal-title":"J Bone Miner Res"},{"issue":"7","key":"2023022002591409000_","doi-asserted-by":"crossref","first-page":"2604","DOI":"10.1210\/en.2015-2028","article-title":"Frequency of teriparatide administration affects the histological pattern of bone formation in young adult male mice","volume":"157","author":"Yamamoto","year":"2016","journal-title":"Endocrinology"},{"issue":"4","key":"2023022002591409000_","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1038\/ki.2014.349","article-title":"Bone histomorphometry before and after long-term treatment with cinacalcet in dialysis patients with secondary hyperparathyroidism","volume":"87","author":"Behets","year":"2015","journal-title":"Kidney Int"},{"issue":"6","key":"2023022002591409000_","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1681\/ASN.2014040414","article-title":"Effects of cinacalcet on fracture events in patients receiving hemodialysis: the EVOLVE trial","volume":"26","author":"Moe","year":"2015","journal-title":"J Am Soc Nephrol"},{"issue":"3","key":"2023022002591409000_","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1111\/1744-9987.13434","article-title":"Evocalcet: a new oral calcimimetic for dialysis patients with secondary hyperparathyroidism","volume":"24","author":"Akizawa","year":"2020","journal-title":"Ther Apher Dial"},{"issue":"5","key":"2023022002591409000_","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1080\/17446651.2020.1780911","article-title":"Development of evocalcet for unmet needs among calcimimetic agents","volume":"15","author":"Hamano","year":"2020","journal-title":"Expert Rev Endocrinol Metab"},{"issue":"11","key":"2023022002591409000_","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.1016\/j.bmcl.2018.04.055","article-title":"Discovery of evocalcet, a next-generation calcium-sensing receptor agonist for the treatment of hyperparathyroidism","volume":"28","author":"Miyazaki","year":"2018","journal-title":"Bioorg Med Chem Lett"},{"issue":"4","key":"2023022002591409000_","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0195316","article-title":"A novel calcimimetic agent, evocalcet (MT-4580\/KHK7580), suppresses the parathyroid cell function with little effect on the gastrointestinal tract or CYP isozymes in vivo and in vitro","volume":"13","author":"Kawata","year":"2018","journal-title":"PLoS One"},{"issue":"4","key":"2023022002591409000_","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1016\/j.kint.2018.05.013","article-title":"Head-to-head comparison of the new calcimimetic agent evocalcet with cinacalcet in Japanese hemodialysis patients with secondary hyperparathyroidism","volume":"94","author":"Fukagawa","year":"2018","journal-title":"Kidney Int"},{"issue":"2","key":"2023022002591409000_","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S8756-3282(99)00263-X","article-title":"Daily intermittent decreases in serum levels of parathyroid hormone have an anabolic-like action on the bones of uremic rats with low-turnover bone and osteomalacia","volume":"26","author":"Ishii","year":"2000","journal-title":"Bone"},{"issue":"6","key":"2023022002591409000_","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1002\/jbmr.5650020617","article-title":"Bone histomorphometry: standardization of nomenclature, symbols, and units. Report of the ASBMR Histomorphometry Nomenclature Committee","volume":"2","author":"Parfitt","year":"1987","journal-title":"J Bone Miner Res"},{"issue":"2","key":"2023022002591409000_","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1210\/en.2014-1033","article-title":"Protein malnutrition attenuates bone anabolic response to PTH in female rats","volume":"156","author":"Ammann","year":"2015","journal-title":"Endocrinology"},{"issue":"2","key":"2023022002591409000_","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1007\/s00774-016-0745-z","article-title":"Fibroblast growth factor-21 restores insulin sensitivity but induces aberrant bone microstructure in obese insulin-resistant rats","volume":"35","author":"Charoenphandhu","year":"2017","journal-title":"J Bone Miner Metab"},{"issue":"4","key":"2023022002591409000_","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1093\/oxfordjournals.jbchem.a022505","article-title":"A general method for rapid purification of soluble versions of glycosylphosphatidylinositol-anchored proteins expressed in insect cells: an application for human tissue-nonspecific alkaline phosphatase","volume":"126","author":"Oda","year":"1999","journal-title":"J Biochem"},{"key":"2023022002591409000_","doi-asserted-by":"crossref","first-page":"110931","DOI":"10.1016\/j.mce.2020.110931","article-title":"Active sites of human MEPE-ASARM regulating bone matrix mineralization","volume":"517","author":"Minamizaki","year":"2020","journal-title":"Mol Cell Endocrinol"},{"issue":"5","key":"2023022002591409000_","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1093\/jmicro\/dfz021","article-title":"Histochemical examination on principal collagen fibers in periodontal ligaments of ascorbic acid-deficient ODS-od\/od rats","volume":"68","author":"Hasegawa","year":"2019","journal-title":"Microscopy"},{"issue":"3","key":"2023022002591409000_","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1369\/0022155418806865","article-title":"Histological effects of the combined administration of eldecalcitol and a parathyroid hormone in the metaphyseal trabeculae of ovariectomized rats","volume":"67","author":"Hasegawa","year":"2019","journal-title":"J Histochem Cytochem"},{"key":"2023022002591409000_","article-title":"Evocalcet rescues secondary hyperparathyroidism-driven cortical porosity in chronic kidney disease male rats","volume-title":"Endocrinology","author":"Hasegawa","year":"2023"},{"issue":"12","key":"2023022002591409000_","doi-asserted-by":"crossref","first-page":"2014","DOI":"10.1359\/jbmr.1997.12.12.2014","article-title":"Establishment of an osteocyte-like cell line, MLO-Y4","volume":"12","author":"Kato","year":"1997","journal-title":"J Bone Miner Res"},{"issue":"7","key":"2023022002591409000_","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1359\/JBMR.040404","article-title":"Continuous parathyroid hormone induces cortical porosity in the rat: effects on bone turnover and mechanical properties","volume":"19","author":"Lotinun","year":"2004","journal-title":"J Bone Miner Res"},{"issue":"8","key":"2023022002591409000_","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1002\/jbmr.1916","article-title":"Rapid cortical bone loss in patients with chronic kidney disease","volume":"28","author":"Nickolas","year":"2013","journal-title":"J Bone Miner Res"},{"issue":"4","key":"2023022002591409000_","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1002\/jbmr.1784","article-title":"Differing effects of PTH 1\u201334, PTH 1\u201384, and zoledronic acid on bone microarchitecture and estimated strength in postmenopausal women with osteoporosis: an 18-month open-labeled observational study using HR-pQCT","volume":"28","author":"Hansen","year":"2013","journal-title":"J Bone Miner Res"},{"issue":"10","key":"2023022002591409000_","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1369\/0022155420961375","article-title":"Osteocytic osteolysis in PTH-treated wild-type and Rankl\u2212\/\u2212 mice examined by transmission electron microscopy, atomic force microscopy, and isotope microscopy","volume":"68","author":"Hongo","year":"2020","journal-title":"J Histochem Cytochem"},{"issue":"1","key":"2023022002591409000_","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/BF02279101","article-title":"Osteocytic osteolysis","volume":"4","author":"B\u00e9langer","year":"1969","journal-title":"Calcif Tissue Res"},{"issue":"5","key":"2023022002591409000_","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1002\/jbmr.1567","article-title":"Demonstration of osteocytic perilacunar\/canalicular remodeling in mice during lactation","volume":"27","author":"Qing","year":"2012","journal-title":"J Bone Miner Res"},{"issue":"11","key":"2023022002591409000_","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.1359\/jbmr.2001.16.11.2017","article-title":"Dentin matrix protein 1 is predominantly expressed in chicken and rat osteocytes but not in osteoblasts","volume":"16","author":"Toyosawa","year":"2001","journal-title":"J Bone Miner Res"},{"issue":"2","key":"2023022002591409000_","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1359\/jbmr.2002.17.2.311","article-title":"Ontogeny of Phex\/PHEX protein expression in mouse embryo and subcellular localization in osteoblasts","volume":"17","author":"Thompson","year":"2002","journal-title":"J Bone Miner Res"},{"issue":"3","key":"2023022002591409000_","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1007\/s00774-003-0468-9","article-title":"Matrix extracellular phosphoglycoprotein (MEPE) is highly expressed in osteocytes in human bone","volume":"22","author":"Nampei","year":"2004","journal-title":"J Bone Miner Metab"},{"issue":"11","key":"2023022002591409000_","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1038\/ng1905","article-title":"Loss of DMP1 causes rickets and osteomalacia and identifies a role for osteocytes in mineral metabolism","volume":"38","author":"Feng","year":"2006","journal-title":"Nat Genet"},{"issue":"1","key":"2023022002591409000_","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.bone.2004.09.015","article-title":"Surface plasmon resonance (SPR) confirms that MEPE binds to PHEX via the MEPE-ASARM motif: a model for impaired mineralization in X-linked rickets (HYP)","volume":"36","author":"Rowe","year":"2005","journal-title":"Bone"},{"issue":"1","key":"2023022002591409000_","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1007\/s00223-009-9313-z","article-title":"MEPE's diverse effects on mineralization","volume":"86","author":"Boskey","year":"2010","journal-title":"Calcif Tissue Int"},{"issue":"3","key":"2023022002591409000_","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1530\/JOE-12-0143","article-title":"The importance of the SIBLING family of proteins on skeletal mineralisation and bone remodelling","volume":"21","author":"Staines","year":"2012","journal-title":"J Endocrinol"},{"issue":"1","key":"2023022002591409000_","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/S0006-291X(02)02125-3","article-title":"Inhibition of MEPE cleavage by Phex","volume":"297","author":"Guo","year":"2002","journal-title":"Biochem Biophys Res Commun"},{"issue":"2","key":"2023022002591409000_","first-page":"722","article-title":"Aberrant Phex function in osteoblasts and osteocytes alone underlies murine X-linked hypophosphatemia","volume":"118","author":"Yuan","year":"2008","journal-title":"J Clin Invest"},{"issue":"1","key":"2023022002591409000_","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1146\/annurev.med.051308.111339","article-title":"Regulation of phosphate homeostasis by PTH, vitamin D, and FGF23","volume":"61","author":"Bergwitz","year":"2010","journal-title":"Annu Rev Med"},{"issue":"18","key":"2023022002591409000_","doi-asserted-by":"crossref","first-page":"3985","DOI":"10.1113\/jphysiol.2014.273979","article-title":"Regulation of serum phosphate","volume":"592","author":"Lederer","year":"2014","journal-title":"J Physiol"},{"issue":"3","key":"2023022002591409000_","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/S8756-3282(00)00346-X","article-title":"Inorganic phosphate induces apoptosis of osteoblast-like cells in culture","volume":"27","author":"Meleti","year":"2000","journal-title":"Bone"},{"issue":"23","key":"2023022002591409000_","doi-asserted-by":"crossref","first-page":"20316","DOI":"10.1074\/jbc.M006492200","article-title":"Matrix regulation of skeletal cell apoptosis. Role of calcium and phosphate ions","volume":"276","author":"Adams","year":"2001","journal-title":"J Biol Chem"},{"issue":"9","key":"2023022002591409000_","doi-asserted-by":"crossref","first-page":"2724","DOI":"10.1093\/ndt\/gfm312","article-title":"Calcimimetic increases osteoprotegerin and decreases fetuin-A levels in dialysis patients","volume":"22","author":"Messa","year":"2007","journal-title":"Nephrol Dial Transplant"},{"key":"2023022002591409000_","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.bone.2015.10.008","article-title":"FGF23-regulated production of fetuin-A (AHSG) in osteocytes","volume":"83","author":"Mattinzoli","year":"2016","journal-title":"Bone"},{"issue":"4","key":"2023022002591409000_","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1097\/MNH.0000000000000609","article-title":"Calciprotein particles: mineral behaving badly?","volume":"29","author":"Smith","year":"2020","journal-title":"Curr Opin Nephrol Hypertens"}],"container-title":["Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/endo\/advance-article-pdf\/doi\/10.1210\/endocr\/bqad022\/48974559\/bqad022.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/endo\/article-pdf\/164\/4\/bqad022\/49254469\/bqad022.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/endo\/article-pdf\/164\/4\/bqad022\/49254469\/bqad022.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,23]],"date-time":"2023-03-23T05:58:36Z","timestamp":1679551116000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/endo\/article\/doi\/10.1210\/endocr\/bqad022\/7013989"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,31]]},"references-count":53,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,2,11]]}},"URL":"https:\/\/doi.org\/10.1210\/endocr\/bqad022","relation":{},"ISSN":["1945-7170"],"issn-type":[{"value":"1945-7170","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2023,4,1]]},"published":{"date-parts":[[2023,1,31]]},"article-number":"bqad022"}}